162 related articles for article (PubMed ID: 21734784)
1. Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes.
Han B; Shi XL; Xiao JQ; Zhang Y; Chu XH; Gu JY; Tan JJ; Gu ZZ; Ding YT
World J Gastroenterol; 2011 Jun; 17(22):2774-80. PubMed ID: 21734784
[TBL] [Abstract][Full Text] [Related]
2. No enhanced expression and infectivity of porcine endogenous retrovirus in primary porcine hepatocytes with chitosan nanofiber scaffold.
Han B; Shi X; Gu ZZ; Xiao J; Chu X; Gu J; Zhang Y; Tan J; Ding Y
J Biomed Nanotechnol; 2011 Jun; 7(3):377-83. PubMed ID: 21830478
[TBL] [Abstract][Full Text] [Related]
3. Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes.
Nyberg SL; Hibbs JR; Hardin JA; Germer JJ; Platt JL; Paya CV; Wiesner RH
Liver Transpl; 2000 Jan; 6(1):76-84. PubMed ID: 10648582
[TBL] [Abstract][Full Text] [Related]
4. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells.
Frühauf JH; Mertsching H; Giri S; Frühauf NR; Bader A
Liver Int; 2009 Nov; 29(10):1553-61. PubMed ID: 19686312
[TBL] [Abstract][Full Text] [Related]
5. Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system.
Wang HH; Wang YJ; Liu HL; Liu J; Huang YP; Guo HT; Wang YM
World J Gastroenterol; 2006 Feb; 12(8):1287-91. PubMed ID: 16534887
[TBL] [Abstract][Full Text] [Related]
6. No transmission of porcine endogenous retrovirus in an acute liver failure model treated by a novel hybrid bioartificial liver containing porcine hepatocytes.
Han B; Shi XL; Zhang Y; Gu ZZ; Yuan XW; Ren HZ; Qiu Y; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):492-501. PubMed ID: 26459725
[TBL] [Abstract][Full Text] [Related]
7. A study on the susceptibility of allogeneic human hepatocytes to porcine endogenous retrovirus.
Yue S; Zhang Y; Gao Y
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3486-91. PubMed ID: 26439047
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus.
Kuddus R; Patzer JF; Lopez R; Mazariegos GV; Meighen B; Kramer DJ; Rao AS
Transplantation; 2002 Feb; 73(3):420-9. PubMed ID: 11884940
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the transfer of porcine endogenous retroviruses across the membrane in bioartificial livers.
Shi XL; Han B; Tan JJ; Yuan X; Zhang Y; Xiao JQ; Gu ZZ; Ding YT
Int J Artif Organs; 2012 May; 35(5):385-91. PubMed ID: 22505203
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor.
Liu Q; Liu Z; Dalakas E
World J Gastroenterol; 2005 Aug; 11(30):4727-30. PubMed ID: 16094718
[TBL] [Abstract][Full Text] [Related]
11. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system.
Pitkin Z; Mullon C
Artif Organs; 1999 Sep; 23(9):829-33. PubMed ID: 10491030
[TBL] [Abstract][Full Text] [Related]
12. [New evidence of porcine endogenous retrovirus transmission with new bio-artificial liver system: a experimental study].
Shi XL; Han B; Zhang Y; Gu JY; Chu XH; Xiao JQ; Tan JJ; Ding YT
Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):45-9. PubMed ID: 22464706
[TBL] [Abstract][Full Text] [Related]
13. Comparison of porcine endogenous retroviruses infectious potential in supernatants of producer cells and in cocultures.
Costa MR; Fischer N; Gulich B; Tönjes RR
Xenotransplantation; 2014; 21(2):162-73. PubMed ID: 24447212
[TBL] [Abstract][Full Text] [Related]
14. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.
Denner J; Schuurman HJ; Patience C
Xenotransplantation; 2009; 16(4):239-48. PubMed ID: 19799764
[TBL] [Abstract][Full Text] [Related]
15. Assessment of porcine endogenous retrovirus transmission across an alginate barrier used for the encapsulation of porcine islets.
Crossan C; Mourad NI; Smith K; Gianello P; Scobie L
Xenotransplantation; 2018 Nov; 25(6):e12409. PubMed ID: 29782054
[TBL] [Abstract][Full Text] [Related]
16. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver.
Di Nicuolo G; van de Kerkhove MP; Hoekstra R; Beld MG; Amoroso P; Battisti S; Starace M; di Florio E; Scuderi V; Scala S; Bracco A; Mancini A; Chamuleau RA; Calise F
Xenotransplantation; 2005 Jul; 12(4):286-92. PubMed ID: 15943777
[TBL] [Abstract][Full Text] [Related]
17. Existence of proviral porcine endogenous retrovirus in fresh and decellularised porcine tissues.
Prabha S; Verghese S
Indian J Med Microbiol; 2008; 26(3):228-32. PubMed ID: 18695319
[TBL] [Abstract][Full Text] [Related]
18. Porcine endogenous retroviral mRNAs in pancreas and a panel of tissues from specific pathogen-free pigs.
Clémenceau B; Lalain S; Martignat L; Saï P
Diabetes Metab; 1999 Dec; 25(6):518-25. PubMed ID: 10633879
[TBL] [Abstract][Full Text] [Related]
19. Pig islet xenotransplantation: activation of porcine endogenous retrovirus in the immediate post-transplantation period.
Schmidt P; Forsman A; Andersson G; Blomberg J; Korsgren O
Xenotransplantation; 2005 Nov; 12(6):450-6. PubMed ID: 16202068
[TBL] [Abstract][Full Text] [Related]
20. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]